Us Physicalrapy Stock Buy Hold or Sell Recommendation
| USPH Stock | USD 98.76 1.68 1.73% |
Given the investment horizon of 90 days and your below-average risk tolerance, our recommendation regarding US Physicalrapy is 'Strong Hold'. The recommendation algorithm takes into account all of US Physicalrapy's available fundamental, technical, and predictive indicators you will find on this site.
Check out US Physicalrapy Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide. In addition, we conduct extensive research on individual companies such as USPH and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards US Physicalrapy. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
USPH |
Execute US Physicalrapy Buy or Sell Advice
The USPH recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on US Physicalrapy. Macroaxis does not own or have any residual interests in US Physicalrapy or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute US Physicalrapy's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Hold
Market Performance | OK | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
US Physicalrapy Trading Alerts and Improvement Suggestions
| Over 98.0% of the company outstanding shares are owned by institutional investors | |
| Latest headline from MacroaxisInsider: Acquisition by Bernard Harris of 1600 shares of US Physicalrapy subject to Rule 16b-3 |
US Physicalrapy Returns Distribution Density
The distribution of US Physicalrapy's historical returns is an attempt to chart the uncertainty of US Physicalrapy's future price movements. The chart of the probability distribution of US Physicalrapy daily returns describes the distribution of returns around its average expected value. We use US Physicalrapy price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of US Physicalrapy returns is essential to provide solid investment advice for US Physicalrapy.
| Mean Return | 0.30 | Value At Risk | -2.56 | Potential Upside | 3.06 | Standard Deviation | 2.61 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of US Physicalrapy historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
USPH Stock Institutional Investors
| Shares | Geode Capital Management, Llc | 2024-09-30 | 343.1 K | Riverbridge Partners Llc | 2024-09-30 | 336.1 K | Gw&k Investment Management, Llc | 2024-09-30 | 320 K | Envestnet Asset Management Inc | 2024-09-30 | 249.6 K | Northern Trust Corp | 2024-09-30 | 229.8 K | Fred Alger Management, Llc | 2024-09-30 | 172.3 K | Fmr Inc | 2024-09-30 | 164.5 K | Bank Of New York Mellon Corp | 2024-06-30 | 157.1 K | Bank Of America Corp | 2024-06-30 | 150.7 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 2.4 M | Blackrock Inc | 2024-06-30 | 2.3 M |
US Physicalrapy Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 180K | 9.4M | (4.4M) | 3.0M | 121.2M | 127.3M | |
| Free Cash Flow | 52.3M | 92.4M | 68.2M | 50.3M | 72.7M | 76.3M | |
| Other Non Cash Items | (560K) | 5.7M | 5.1M | 10.2M | 22.3M | 23.4M | |
| Capital Expenditures | 10.2M | 7.6M | 8.2M | 8.2M | 9.3M | 5.3M | |
| Net Income | 57.3M | 52.5M | 57.9M | 43.4M | 37.2M | 20.1M | |
| End Period Cash Flow | 23.5M | 32.9M | 28.6M | 31.6M | 152.8M | 160.5M | |
| Depreciation | 10.1M | 10.5M | 11.6M | 14.7M | 15.7M | 16.5M | |
| Change To Inventory | (742K) | 4.2M | (12.4M) | (4.7M) | (5.4M) | (5.6M) | |
| Dividends Paid | 14.6M | 4.1M | 18.8M | 21.3M | 24.1M | 25.3M | |
| Investments | (221K) | (111K) | 427K | (81.3M) | (80.0M) | (76.0M) | |
| Change Receivables | (4.5M) | (8.9M) | 2.6M | (11.0M) | (9.9M) | (9.4M) | |
| Net Borrowings | 6.6M | (31.0M) | 93.1M | 64.2M | 73.8M | 77.5M | |
| Change To Netincome | 16.6M | 14.4M | 35.7M | 33.1M | 38.0M | 39.9M |
US Physicalrapy Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to US Physicalrapy or Health Care Providers & Services sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that US Physicalrapy's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a USPH stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.01 | |
β | Beta against Dow Jones | 2.37 | |
σ | Overall volatility | 2.64 | |
Ir | Information ratio | 0.06 |
US Physicalrapy Volatility Alert
US Physicalrapy has relatively low volatility with skewness of 4.61 and kurtosis of 30.41. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure US Physicalrapy's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact US Physicalrapy's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.US Physicalrapy Fundamentals Vs Peers
Comparing US Physicalrapy's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze US Physicalrapy's direct or indirect competition across all of the common fundamentals between US Physicalrapy and the related equities. This way, we can detect undervalued stocks with similar characteristics as US Physicalrapy or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of US Physicalrapy's fundamental indicators could also be used in its relative valuation, which is a method of valuing US Physicalrapy by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare US Physicalrapy to competition |
| Fundamentals | US Physicalrapy | Peer Average |
| Return On Equity | 0.0475 | -0.31 |
| Return On Asset | 0.0424 | -0.14 |
| Profit Margin | 0.04 % | (1.27) % |
| Operating Margin | 0.11 % | (5.51) % |
| Current Valuation | 1.63 B | 16.62 B |
| Shares Outstanding | 15.1 M | 571.82 M |
| Shares Owned By Insiders | 1.57 % | 10.09 % |
| Shares Owned By Institutions | 98.43 % | 39.21 % |
| Number Of Shares Shorted | 682.02 K | 4.71 M |
| Price To Earning | 34.35 X | 28.72 X |
| Price To Book | 3.09 X | 9.51 X |
| Price To Sales | 2.33 X | 11.42 X |
| Revenue | 604.8 M | 9.43 B |
| Gross Profit | 112.02 M | 27.38 B |
| EBITDA | 74.37 M | 3.9 B |
| Net Income | 37.22 M | 570.98 M |
| Cash And Equivalents | 48.57 M | 2.7 B |
| Cash Per Share | 3.73 X | 5.01 X |
| Total Debt | 258.59 M | 5.32 B |
| Debt To Equity | 0.57 % | 48.70 % |
| Current Ratio | 1.43 X | 2.16 X |
| Book Value Per Share | 32.02 X | 1.93 K |
| Cash Flow From Operations | 81.98 M | 971.22 M |
| Short Ratio | 5.95 X | 4.00 X |
| Earnings Per Share | 0.88 X | 3.12 X |
| Price To Earnings To Growth | 3.92 X | 4.89 X |
| Target Price | 107.4 | |
| Number Of Employees | 3.9 K | 18.84 K |
| Beta | 1.39 | -0.15 |
| Market Capitalization | 1.49 B | 19.03 B |
| Total Asset | 997.24 M | 29.47 B |
| Retained Earnings | 223.77 M | 9.33 B |
| Working Capital | 131.19 M | 1.48 B |
Note: Acquisition by Bernard Harris of 1600 shares of US Physicalrapy subject to Rule 16b-3 [view details]
US Physicalrapy Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as USPH . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About US Physicalrapy Buy or Sell Advice
When is the right time to buy or sell US Physicalrapy? Buying financial instruments such as USPH Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having US Physicalrapy in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Utilities - Regulated Electric Thematic Idea Now
Utilities - Regulated Electric
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Utilities - Regulated Electric theme has 7 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Utilities - Regulated Electric Theme or any other thematic opportunities.
| View All Next | Launch |
Check out US Physicalrapy Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of US Physicalrapy. If investors know USPH will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about US Physicalrapy listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.24) | Dividend Share 1.75 | Earnings Share 0.88 | Revenue Per Share 42.489 | Quarterly Revenue Growth 0.12 |
The market value of US Physicalrapy is measured differently than its book value, which is the value of USPH that is recorded on the company's balance sheet. Investors also form their own opinion of US Physicalrapy's value that differs from its market value or its book value, called intrinsic value, which is US Physicalrapy's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because US Physicalrapy's market value can be influenced by many factors that don't directly affect US Physicalrapy's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between US Physicalrapy's value and its price as these two are different measures arrived at by different means. Investors typically determine if US Physicalrapy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, US Physicalrapy's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.